3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Parathyroid Neoplasms
1
Neovascularization, Pathologic
1
Hyperparathyroidism, Primary
1
Carcinoma, Renal Cell
1
Interventions
Magnetic Resonance Spectroscopy
13
Cisplatin
12
Specimen Handling
11
pembrolizumab
10
Radiotherapy, Intensity-Modulated
7
Cetuximab
7
Platinum
6
1,2-diaminocyclohexaneplatinum II citrate
6
Taxes
4
Surgical Procedures, Operative
4
Radiotherapy
4
Paclitaxel
4
Carboplatin
4
Biopsy
4
(225)Ac-DOTA-c(RGDyK)
4
Radiation
3
Chemoradiotherapy
3
ipatasertib
2
X-Rays
2
Surveys and Questionnaires
2
Interviews as Topic
2
Immunoglobulin G
2
Fluorodeoxyglucose F18
2
Docetaxel
2
Disulfides
2
sacituzumab govitecan
1
peposertib
1
merphos
1
durvalumab
1
dehydroftorafur
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Hypopharyngeal Neoplasms
×
Rubidium-82
×
1 year
×
Clear all
No trials found.